|
Press Releases |
|
|
|
Monday, March 14, 2022 |
|
Jacobson Pharma's Chairman Uplifts Shareholding to Above 60% |
Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma Corporation Limited (the "Company"; together with its subsidiaries, the "Group"; Stock Code: 2633), a leading company engaged in the research more info >> |
|
Friday, November 26, 2021 |
|
雅各臣公布二零二二财年中期业绩 |
从事基础药物、专科药物及品牌医疗保健产品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司(「雅各臣」或「公司」;股份代号:2633 )今天公布公司及其附属公司(统称「集团」)截至二零二一年九月三十日止六个月(「报告期」)的中期业绩。 more info >> |
|
雅各臣公佈二零二二財年中期業績 |
從事基礎藥物、專科藥物及品牌醫療保健產品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司(「雅各臣」或「公司」;股份代號:2633 )今天公佈公司及其附屬公司(統稱「集團」)截至二零二一年九月三十日止六個月(「報告期」)的中期業績。 more info >> |
|
Jacobson Pharma Announces FY2022 Interim Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of essential medicines more info >> |
|
Tuesday, June 29, 2021 |
|
雅各臣公布二零二一财年全年业绩 |
从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司(「雅各臣」或「公司」;股份代号:2633 )今天公布公司及其附属公司(统称「集团」)于截至二零二一年三月三十一日止年度(「二零二一财年」或「报告期」)的全年业绩。 more info >> |
|
雅各臣公佈二零二一財年全年業績 |
從事基礎藥物、專科藥物及品牌醫療保健品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司(「雅各臣」或「公司」;股份代號:2633 )今天公佈公司及其附屬公司(統稱「集團」)於截至二零二一年三月三十一日止年度(「二零二一財年」或「報告期」)的全年業績。 more info >> |
|
Jacobson Pharma Announces FY2021 Annual Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products more info >> |
|
Friday, February 5, 2021 |
|
健倍苗苗(保健)有限公司於香港聯交所主板掛牌上市 |
健倍苗苗(保健)有限公司 (「健倍苗苗」 或「公司」,連同其附屬公司統稱「集團」),一家總部設於香港的領先品牌醫療保健品推廣及分銷公司,業務遍及大中華、東南亞及其他選定國家,今天於香港聯合交易所有限公司(「香港聯交所」)主板正式掛牌買賣,股份代號為2161。 more info >> |
|
JBM (Healthcare) Limited Debuts on The Main Board of SEHK |
JBM (Healthcare) Limited ("JBM Healthcare" or "Company", together with its subsidiaries, the "Group"), a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia and certain other countries, started trading today on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") under stock code 2161. more info >> |
|
Monday, January 25, 2021 |
|
健倍苗苗(保健)有限公司将从雅各臣科研制药有限公司分拆 |
健倍苗苗(保健)有限公司(「健倍苗苗」 或「公司」,连同其附属公司统称「集团」),一家总部设于香港的领先品牌医疗保健品推广及分销公司,产品据点遍及大中华、东南亚及其他选定国家,今天公布其股份于香港联合交易所有限公司(「香港联交所」)主板上市计划详情。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Global News and Publishing Platform Gnomi Launches Paid Journalism Program
May 13, 2024 23:15 HKT/SGT
|
|
|
Creation Business Consultants Expands Presence with New Office in Hong Kong
May 13, 2024 20:20 HKT/SGT
|
|
|
$9.25 Million in Investments Committed to Start-ups during FinTech World Cup at Dubai FinTech Summit
May 13, 2024 19:58 HKT/SGT
|
|
|
富士通、スーパーコンピュータ「富岳」の世界ランキング結果を発表
May 13, 2024 19:00: JST
|
|
|
Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
May 13, 2024 18:32 JST
|
|
|
Eisai's Antiepileptic Drug Fycompa Approved in China for Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures
May 13, 2024 17:06 JST
|
|
|
Datacloud APAC: Charting the Course for APAC's Cloud Future
May 13, 2024 16:00 HKT/SGT
|
|
|
Creation Business Consultants Expands Presence with New Office in Hong Kong
May 13, 2024 15:30 HKT/SGT
|
|
|
Thailand: Ivy launches plum and tamarind juice drinks in SIG XSlimBloc carton packs
May 13, 2024 15:00 HKT/SGT
|
|
|
3rd Annual Clean Power & New Energy 2024
May 13, 2024 14:03 HKT/SGT
|
|
|
Ogier and TOYOTA GAZOO Racing triumph again
May 13, 2024 14:36 JST
|
|
|
日清食品公布2024年首季度业绩
May 13, 2024 13:00 HKT/SGT
|
|
|
日清食品公布2024年首季度業績
May 13, 2024 12:57 HKT/SGT
|
|
|
Spa points haul for TOYOTA GAZOO Racing
May 13, 2024 13:56 JST
|
|
|
Nissin Foods Announces 2024 Q1 Financial Results
May 13, 2024 12:52 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|